Med-V1: Small Language Models for Zero-shot and Scalable Biomedical Evidence Attribution

Med-V1: Small Language Models for Zero-shot and Scalable Biomedical Evidence Attribution | Signal Canvas | ScienceToStartup

Page Freshness

Signal Canvas proof surface

Canonical route: /signal-canvas/med-v1-small-language-models-for-zero-shot-and-scalable-biomedical-evidence-attribution

stale

Proof freshness: stale
Proof status: unverified
Display score: 8/10
Last proof check: 2026-04-02
Score updated: 2026-04-02
Score fresh until: 2026-05-02
References: 0
Source count: 0
Coverage: 17%

This page is showing the last landed evidence receipt and score bundle because the latest proof data is outside the freshness window.

Agent Handoff

Canonical ID med-v1-small-language-models-for-zero-shot-and-scalable-biomedical-evidence-attribution | Route /signal-canvas/med-v1-small-language-models-for-zero-shot-and-scalable-biomedical-evidence-attribution

REST example

curl https://sciencetostartup.com/api/v1/agent-handoff/signal-canvas/med-v1-small-language-models-for-zero-shot-and-scalable-biomedical-evidence-attribution

MCP example

{
  "tool": "search_signal_canvas",
  "arguments": {
    "mode": "paper",
    "paper_ref": "med-v1-small-language-models-for-zero-shot-and-scalable-biomedical-evidence-attribution",
    "query_text": "Summarize Med-V1: Small Language Models for Zero-shot and Scalable Biomedical Evidence Attribution"
  }
}

source_context

{
  "surface": "signal_canvas",
  "mode": "paper",
  "query": "Med-V1: Small Language Models for Zero-shot and Scalable Biomedical Evidence Attribution",
  "normalized_query": "2603.05308",
  "route": "/signal-canvas/med-v1-small-language-models-for-zero-shot-and-scalable-biomedical-evidence-attribution",
  "paper_ref": "med-v1-small-language-models-for-zero-shot-and-scalable-biomedical-evidence-attribution",
  "topic_slug": null,
  "benchmark_ref": null,
  "dataset_ref": null
}

Evidence Receipt

Route status: building

Claims: 7

References: Pending verification

Proof: Verification pending

Freshness state: computing

Source paper: Med-V1: Small Language Models for Zero-shot and Scalable Biomedical Evidence Attribution

PDF: https://arxiv.org/pdf/2603.05308v1

Source count: Pending verification

Coverage: 17%

Last proof check: 2026-04-02T02:30:40.136Z

Signal Canvas receipt window

Watch and verify: Med-V1: Small Language Models for Zero-shot and Scalable Biomedical Evidence Attribution

/buildability/med-v1-small-language-models-for-zero-shot-and-scalable-biomedical-evidence-attribution

Watchwatch

Subject: Med-V1: Small Language Models for Zero-shot and Scalable Biomedical Evidence Attribution

Verdict

Watch

Verdict is Watch because viability or proof quality is intermediate and should be re-evaluated before execution.

Preparing verified analysis

GitHub Code Pulse

No public code linked for this paper yet.

Claim map

Strong 7Mixed 0Weak 0

Evidencepartial
Med-V1 substantially outperforms (+27.0% to +71.3%) its base models on five biomedical benchmarks unified into a verification format.
Implicationpartial
Directly stated in the abstract with specific performance metrics.
Verificationpartial
partial
Evidencepartial
Despite its smaller size, Med-V1 performs comparably to frontier LLMs such as GPT-5, along with high-quality explanations for its predictions.
Implicationpartial
Explicitly stated in the abstract that it performs comparably to GPT-5.
Verificationpartial
partial
Evidencepartial
Trained on high-quality synthetic data newly developed in this study
Implicationpartial
Directly stated in the abstract and analysis excerpt.
Verificationpartial
partial
Evidencepartial
Results show that the format instruction strongly affects citation validity and hallucination, with GPT-5 generating more claims but exhibiting hallucination rates similar to GPT-4o.
Implicationpartial
Directly stated in the abstract as a result from a use case study.
Verificationpartial
partial
Evidencepartial
Med-V1 can automatically identify high-stakes evidence misattributions in clinical practice guidelines, revealing potentially negative public health impacts that are otherwise challenging to identify at scale.
Implicationpartial
Directly stated in the abstract as a demonstrated use case.
Verificationpartial
partial
Evidencepartial
Scaling the solution outside biomedical verification could require new datasets and adaptations. Current reliance on synthetic data might miss nuances captured in naturally occurring datasets, potentially impacting real-world application accuracy.
Implicationpartial
Explicitly stated in the analysis excerpt as a caveat.
Verificationpartial
partial
Evidencepartial
Med-V1 provides an efficient and accurate lightweight alternative to frontier LLMs for practical and real-world applications in biomedical evidence attribution and verification tasks.
Implicationpartial
Directly stated in the abstract as a conclusion.
Verificationpartial
partial

Author intelligence and commercialization panels stay hidden until the proof receipt is verified, cites at least 3 references, includes at least 2 sources, and clears 50% coverage. The paper narrative and citation surfaces remain public while verification is pending.

Med-V1: Small Language Models for Zero-shot and Scalable Biomedical Evidence Attribution

Use Signal Canvas as the narrative proof surface

Use this Signal Canvas via API or MCP

Signal Canvas proof surface